Gene · 3093
Papers3,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| USP10 Regulates ZEB1 Ubiquitination and Protein Stability to Inhibit ZEB1-Mediated Colorectal Cancer Metastasis. | Mol Cancer Res | 2023 | 36940483 | PubTator, text mining | PubMed |
| Analysis of Communal Molecular Mechanism Between Chronic Obstructive Pulmonary Disease and Osteoporosis. | Int J Chron Obstruct Pulmon Dis | 2023 | 36937804 | PubTator, text mining | PubMed |
| Identification and validation of DLX4 as a prognostic and diagnostic biomarker for clear cell renal cell carcinoma. | Oncol Lett | 2023 | 36936018 | PubTator, text mining | PubMed |
| Plasma exosome-derived circGAPVD1 as a potential diagnostic marker for colorectal cancer. | Transl Oncol | 2023 | 36934637 | PubTator, text mining | PubMed |
| Nutrigenomics in the context of evolution. | Redox Biol | 2023 | 36933390 | PubTator, text mining | PubMed |
| Ubiquitin-modifying enzymes in Huntington's disease. | Front Mol Biosci | 2023 | 36926679 | PubTator, text mining | PubMed |
| Exploring Dysregulated Ferroptosis-Related Genes in Septic Myocardial Injury Based on Human Heart Transcriptomes: Evidence and New Insights. | J Inflamm Res | 2023 | 36923465 | PubTator, text mining | PubMed |
| Exosomal miR-93-5p as an important driver of bladder cancer progression. | Transl Androl Urol | 2023 | 36915886 | PubTator, text mining | PubMed |
| Identification of phytochemical compounds of Fagopyrum dibotrys and their targets by metabolomics, network pharmacology and molecular docking studies. | Heliyon | 2023 | 36911881 | PubTator, text mining | PubMed |
| The abdominal aortic aneurysm-related disease model based on machine learning predicts immunity and m1A/m5C/m6A/m7G epigenetic regulation. | Front Genet | 2023 | 36911406 | PubTator, text mining | PubMed |
| Integrated Bioinformatics Analysis of Shared Genes, miRNA, Biological Pathways and Their Potential Role as Therapeutic Targets in Huntington's Disease Stages. | Int J Mol Sci | 2023 | 36902304 | PubTator, text mining | PubMed |
| Circular RNA- and microRNA-Mediated Post-Transcriptional Regulation of Preadipocyte Differentiation in Adipogenesis: From Expression Profiling to Signaling Pathway. | Int J Mol Sci | 2023 | 36901978 | PubTator, text mining | PubMed |
| Context-Dependent Role of Glucocorticoid Receptor Alpha and Beta in Breast Cancer Cell Behaviour. | Cells | 2023 | 36899920 | PubTator, text mining | PubMed |
| UBE2K regulated by IGF2BP3 promotes cell proliferation and stemness in pancreatic ductal adenocarcinoma. | Int J Oncol | 2023 | 36896783 | PubTator, text mining | PubMed |
| Identification and validation of ferroptosis-related genes and immune infiltration in ischemic cardiomyopathy. | Front Cardiovasc Med | 2023 | 36895830 | PubTator, text mining | PubMed |
| SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted. | Biomark Res | 2023 | 36894973 | PubTator, text mining | PubMed |
| Based on network pharmacology and bioinformatics to analyze the mechanism of action of Astragalus membranaceus in the treatment of vitiligo and COVID-19. | Sci Rep | 2023 | 36890149 | PubTator, text mining | PubMed |
| Bufalin reverses ABCB1-mediated resistance to docetaxel in breast cancer. | Heliyon | 2023 | 36879978 | PubTator, text mining | PubMed |
| To Design Scalable Free Energy Perturbation Networks, Optimal Is Not Enough. | J Chem Inf Model | 2023 | 36878475 | PubTator, text mining | PubMed |
| Microsatellite instability-related prognostic risk score (MSI-pRS) defines a subset of lung squamous cell carcinoma (LUSC) patients with genomic instability and poor clinical outcome. | Front Genet | 2023 | 36873930 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3093/papers?page=21